Navigation Links
Multiple Chemical Sensitivities Are Real

SWANTON, Vt., May 7 /PRNewswire/ -- This May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury Associations worldwide in their effort to spread Multiple Chemical Sensitivity Syndrome awareness.  

AllerAir will make chemical awareness tips and a $50.00 gift certificate available via their website at  Additionally, their blogs and articles will be dedicated to Multiple Chemical Sensitivities and chemical awareness topics for the month of May.  

Multiple Chemical Sensitivities affect over 48 million Americans.  The onset of this debilitating medical condition can cause an allergy-like reaction to even low levels of chemical exposure.  Often referred to as Toxic Injury or Chemical Sensitivity Syndrome, the onset of Multiple Chemical Sensitivities depends on either a single highly toxic chemical encounter, or repeated low-level chemical exposures.

Multiple Chemical Sensitivity Syndrome hits close to home for AllerAir president, Sam Teitelbaum.  He discovered the reality of chemical injury when a close relative was diagnosed with Multiple Chemical Sensitivities in 1990.  Since then, Sam has made it his mission to provide the chemically sensitive with the most inert air purifiers available.

According to Sam, "There are millions of people suffering today because of chemical injury and poor Indoor Air Quality (IAQ).  At AllerAir, we are committed to air quality education and chemical injury prevention and relief.  Millions of people have been affected by multiple chemical sensitivities, but the proliferation of airborne chemicals means that millions more will suffer unless we take stock of our indoor air quality."  

A Cornell study in 2007 revealed that over 3 million tons of toxins and hazardous chemicals are released into the air annually.  This does not include the pesticides used indoors, nor the hundreds of carcinogens found in cleaning products, fragrances and cosmetics.  This May, learn more about Multiple Chemical Sensitivity Syndrome, and how to protect your family.  

AllerAir Since 1996

AllerAir's smart design solutions provide the most effective balance of performance, safety, quality and price.  AllerAir air purifiers are equipped with many pounds of activated carbon, which is proven to be the most efficient way to treat toxic chemicals and gases.  AllerAir's Multiple Chemical Sensitivity air purifiers are built with the most inert products, and clients are able to test and select their own carbon with the carbon test kit.  Chemical exposure is linked to organ and central immune system damage, respiratory disorders and cancer.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
2. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
3. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
4. Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes
5. iPhone Application Designed for Multiple Sclerosis Patients is Launched
6. New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use
7. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
8. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
9. Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
11. Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):